David J Mauro's Net Worth
$7.23 Million
Who is David J Mauro?
David J Mauro has an estimated net worth of $7.23 Million. This is based on reported shares across multiple companies, which include Prelude Therapeutics Inc, Advaxis, Inc., Codiak BioSciences, Inc., and RECURSION PHARMACEUTICALS, INC..
SEC CIK
David J Mauro's CIK is 0001621172
Past Insider Trading and Trends
2015 was David J Mauro's most active year for acquiring shares with 15 total transactions. David J Mauro's most active month to acquire stocks was the month of March. 2021 was David J Mauro's most active year for disposing of shares, totalling 40 transactions. David J Mauro's most active month to dispose stocks was the month of March. 2021 saw David J Mauro paying a total of $311,850.00 for 260,000 shares, this is the most they've acquired in one year. In 2021 David J Mauro cashed out on 330,000 shares for a total of $5,612,920.67, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prelude Therapeutics Inc (PRLD) Snapshot price: $5.18
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$16.43 | -$435,999.91 |
0
|
Scheduled
|
Oct 5
| ||
Form 4
|
—
|
0
|
$19.29 | -$521,932.55 |
0
|
Scheduled
|
Sep 7
| ||
Form 4
|
—
|
0
|
$16.49 | -$438,044.22 |
0
|
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
$14.68 | -$383,757.04 |
0
|
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
$17.17 | -$458,272.35 |
0
|
Scheduled
|
Jun 7
| ||
Form 4
|
—
|
0
|
$21.02 | -$573,741.90 |
0
|
Scheduled
|
May 5
| ||
Form 4
|
—
|
0
|
$18.64 | -$837,597.87 |
0
|
Scheduled
|
Apr 27
| ||
Form 4
|
—
|
0
|
$16.39 | -$725,099.30 |
0
|
Scheduled
|
Apr 19
| ||
Form 4
|
—
|
0
|
$20.12 | -$350,676.15 |
0
|
Scheduled
|
Apr 8
| ||
Form 4
|
—
|
0
|
$20.61 | -$575,949.40 |
0
|
Scheduled
|
Apr 7
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Advaxis, Inc. (ADXS) Snapshot price: $0.14
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.09% | 154 |
$10.06 | $1,549.24 | 166.27K |
Dec 31
| |||
Form 4
| +0.05% | 90 |
$12.07 | $1,086.30 | 166.12K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4
| +0.06% | 96 |
$11.09 | $1,064.64 | 166.03K |
Oct 30
| |||
Form 4
| -12.90% | -24.59K |
$10.08 | -$247,826.88 | 165.93K |
Oct 20
| |||
Form 4
| +0.05% | 104 |
$10.23 | $1,063.92 | 190.52K |
Sep 30
| |||
Form 4
| +0.04% | 72 |
$14.80 | $1,065.60 | 190.41K |
Aug 31
| |||
Form 4
| +0.05% | 92 |
$16.66 | $1,532.72 | 190.34K |
Jul 31
| |||
Form 4
| +0.03% | 52 |
$20.33 | $1,057.16 | 190.25K |
Jun 30
| |||
Form 4
| +0.02% | 42 |
$25.16 | $1,056.72 | 190.2K |
May 29
| |||
Form 4
| +0.03% | 63 |
$16.81 | $1,059.03 | 190.16K |
Apr 30
| |||
Form 4
| +34.82% | 49.09K |
$13.95 | -$80,794.60 | 190.09K |
Mar 30 - Mar 31
| |||
Form 4
| +0.07% | 104 |
$9.00 | $936.00 | 141K |
Feb 27
| |||
Form 4
| +3.76% | 5.11K |
$6.63 | -$14,789.66 | 140.89K |
Dec 10 - Jan 30
| |||
Form 4
| +0.09% | 126 |
$8.01 | $1,009.26 | 135.79K |
Dec 31
| |||
Form 4
| +0.24% | 327 |
$3.12 | $1,020.24 | 135.66K |
Nov 28
| |||
Form 4
| +0.12% | 165 |
$3.18 | $524.70 | 135.34K |
Oct 31
| |||
Form 4
|
∞
| 135.17K |
$2.88 | -$85,910.40 | 135.17K |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Codiak BioSciences, Inc. (CDAKQ) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RECURSION PHARMACEUTICALS, INC. (RXRX) Snapshot price: $5.95
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.80% | -14.15K |
$6.69 | -$94,636.74 | 229.62K |
Aug 15
| |||
Form 4
| -0.35% | -867.00 |
$10.01 | -$8,678.67 | 243.76K |
May 15
| |||
Form 4
| +28.27% | 53.92K |
$10.09 | -$19,090.28 | 244.63K |
Feb 9
| |||
Form 4
|
∞
| 190.71K |
—
|
—
| 190.71K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||